229 related articles for article (PubMed ID: 16582875)
41. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy.
Oike Y; Akao M; Kubota Y; Suda T
Trends Mol Med; 2005 Oct; 11(10):473-9. PubMed ID: 16154386
[TBL] [Abstract][Full Text] [Related]
42. Herbals used for diabetes, obesity, and metabolic syndrome.
Najm W; Lie D
Prim Care; 2010 Jun; 37(2):237-54. PubMed ID: 20493334
[TBL] [Abstract][Full Text] [Related]
43. The 2009 stock conference report: inflammation, obesity and metabolic disease.
Hevener AL; Febbraio MA;
Obes Rev; 2010 Sep; 11(9):635-44. PubMed ID: 20002885
[TBL] [Abstract][Full Text] [Related]
44. Hydrogen sulfide and the metabolic syndrome.
Desai KM; Chang T; Untereiner A; Wu L
Expert Rev Clin Pharmacol; 2011 Jan; 4(1):63-73. PubMed ID: 22115349
[TBL] [Abstract][Full Text] [Related]
45. [Metabolic syndrome: "common soil" for diabetes and atherosclerosis. Novel approaches to an integrated therapy].
Hanefeld M; Metzler W; Köhler C; Schaper F
Herz; 2006 May; 31(3):246-54; quiz 255. PubMed ID: 16770562
[TBL] [Abstract][Full Text] [Related]
46. Metabolic syndrome: a clinical and molecular perspective.
Moller DE; Kaufman KD
Annu Rev Med; 2005; 56():45-62. PubMed ID: 15660501
[TBL] [Abstract][Full Text] [Related]
47. Fibrates in the metabolic syndrome and in diabetes.
Steiner G
Endocrinol Metab Clin North Am; 2004 Sep; 33(3):545-55, vi-vii. PubMed ID: 15262296
[TBL] [Abstract][Full Text] [Related]
48. Disease-specific target selection: a critical first step down the right road.
Roses AD; Burns DK; Chissoe S; Middleton L; St Jean P
Drug Discov Today; 2005 Feb; 10(3):177-89. PubMed ID: 15708532
[TBL] [Abstract][Full Text] [Related]
49. Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome.
Marinangeli CP; Jones PJ
Ann Med; 2010 Jul; 42(5):317-33. PubMed ID: 20486826
[TBL] [Abstract][Full Text] [Related]
50. Flavonoids and metabolic syndrome.
Galleano M; Calabro V; Prince PD; Litterio MC; Piotrkowski B; Vazquez-Prieto MA; Miatello RM; Oteiza PI; Fraga CG
Ann N Y Acad Sci; 2012 Jul; 1259():87-94. PubMed ID: 22758640
[TBL] [Abstract][Full Text] [Related]
51. [New drug targets for the metabolic syndrome and obesity].
Okada-Iwabu M; Yamauchi T; Kadowaki T
Nihon Rinsho; 2012 Nov; 70 Suppl 8():372-7. PubMed ID: 23513868
[No Abstract] [Full Text] [Related]
52. [Research and development strategy of agents for the treatment of metabolic diseases].
Matsuo T; Yukioka H
Nihon Yakurigaku Zasshi; 2010 Nov; 136(5):255-8. PubMed ID: 21089710
[No Abstract] [Full Text] [Related]
53. Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome.
Ricci-Cabello I; Herrera MO; Artacho R
Nutr Rev; 2012 Apr; 70(4):241-55. PubMed ID: 22458697
[TBL] [Abstract][Full Text] [Related]
54. New targets to treat obesity and the metabolic syndrome.
Martin KA; Mani MV; Mani A
Eur J Pharmacol; 2015 Sep; 763(Pt A):64-74. PubMed ID: 26001373
[TBL] [Abstract][Full Text] [Related]
55. [Diagnostic and therapeutic dilemmas in type 2 diabetes].
de Fine Olivarius N
Ugeskr Laeger; 2000 Jun; 162(25):3569-72. PubMed ID: 11016278
[No Abstract] [Full Text] [Related]
56. Could you be at risk for metabolic syndrome? Experts believe Syndrome X contributes to diabetes, heart disease, vascular disease and stroke.
Health News; 2006 Apr; 12(4):6-7. PubMed ID: 16572519
[No Abstract] [Full Text] [Related]
57. [Pharmacological therapeutics for the metabolic syndrome].
Katayama S
Nihon Rinsho; 2006 Dec; 64 Suppl 9():594-8. PubMed ID: 17458288
[No Abstract] [Full Text] [Related]
58. [Combination therapy of leptin and amylin for metabolic syndrome].
Kusakabe T; Ebihara K; Nakao K
Nihon Rinsho; 2011 Jan; 69 Suppl 1():705-10. PubMed ID: 21766685
[No Abstract] [Full Text] [Related]
59. Hidden disruptions in metabolic syndrome: drug-induced nutrient depletion as a pathway to accelerated pathophysiology of metabolic syndrome.
LaValle JB
Altern Ther Health Med; 2006; 12(2):26-31; quiz 32-3. PubMed ID: 16541994
[No Abstract] [Full Text] [Related]
60. Unimolecular Polypharmacy for Treatment of Diabetes and Obesity.
Tschöp MH; Finan B; Clemmensen C; Gelfanov V; Perez-Tilve D; Müller TD; DiMarchi RD
Cell Metab; 2016 Jul; 24(1):51-62. PubMed ID: 27411008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
